Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Pyxis Oncology, Inc.

NASDAQ: PYXS · Life Sciences · 4 alerts · CIK 1782223

Share price
$1.41Close, Nov 16
Market cap
$169M
Shares outstanding
119.61MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Pyxis Oncology, Inc. filings on SEC EDGAR ↗

7:46 AM ET 10-Q
Financial Results

Pyxis Oncology Q3 2026 Results: Net Loss of $20M, Loss Narrows

Pyxis Oncology reported a net loss of $68.6 million for the nine months ended September 30, 2026, compared to $61.5 million in the prior year. The company remains in the clinical stage, heavily dependent on its lead product candidate micvotabart pelidotin (MICVO), and recently completed a private placement of common stock to raise approximately $48.3 million.

Key figure
Net loss $20M
7:40 AM ET 8-K
Financial Results

Pyxis Oncology Financial Results

Pyxis Oncology reported financial results for the third quarter of 2026, ending the period with $114.3 million in cash and equivalents. The company highlighted progress on its lead candidate, micvotabart pelidotin (MICVO), including alignment with the FDA and EMA on the design of a global Phase 3 trial in head and neck cancer planned for mid-2027.

Term
Q3 2026

“The September monotherapy data reinforce our confidence in MICVO’s potential to serve a significant population of patients with previously treated recurrent/metastatic head and neck cancer. We have aligned with feedback received from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on the design of the global Phase 3 Headliner trial and plan to initiate it in mid-2027, with FDA feedback on dose selection expected in the first quarter of 2027.”

Tom Civik, Chief Executive Officer and Chairman of Pyxis Oncology

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.